Golden Biotechnology Corp.

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Golden Biotechnology Corporation (GBC), founded in 2002, is a clinical stage biopharmaceutical company focused on discovery and clinical development of innovative therapeutic new drugs (NCE) to treat serious and rare diseases.

In 2006, GBC discovered from its own screening platforms Antroquinonol® (trade name Hocena®), which has been granted more than 140 patents worldwide for its structure, preparation method and best-in-class applications in oncology, cardio-metabolic syndromes, autoimmune diseases and neurodegenerative diseases.
Ticker:
4132
Exchange:
Taipei Exchange
Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Taiwan
Year Founded:
2002
Main Therapeutic Focus:
Lead Product in Development:
Hocena (Antroquinonol)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
C.E.O.
Golden Biotechnology Corp.